-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
West Pharmaceutical Services Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
- West Pharmaceutical Services Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $5.1M, a 13.6% decline year-over-year.
- West Pharmaceutical Services Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $15.8M, a 44.8% decline year-over-year.
- West Pharmaceutical Services Inc annual Share-based Payment Arrangement, Expense for 2023 was $23.3M, a 1.69% decline from 2022.
- West Pharmaceutical Services Inc annual Share-based Payment Arrangement, Expense for 2022 was $23.7M, a 36.8% decline from 2021.
- West Pharmaceutical Services Inc annual Share-based Payment Arrangement, Expense for 2021 was $37.5M, a 10.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)